Amy Ripka

Founder & CEO at Lucy Therapeutics

Role
CEO & Founder at Lucy Therapeutics
Location
Cambridge, MA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Amy Ripka

24-year successful career track record in drug discovery in multiple disease areas (CNS, CV, anti-infectives, cancer). Currently Amy is CEO of Lucy Therapeutics, a Boston-based, mitochondrial platform biotech revolutionizing treatments for rare and neurological diseases. Prior to her role at LucyTx, she served on the executive leadership teams at SAI Life Sciences and WuXiAppTec. Dr. Ripka previously held positions of scientific leadership at EnVivo Pharmaceuticals, Daiamed and Infinity Pharmaceuticals as well as consulting for other Boston biotechs including FoldRx (acquired by Pfizer) and Hydra Biosciences. She received her PhD in Organic Chemistry from the University of Wisconsin-Madison and subsequently worked in the lab of Nobel Laureate K. Barry Sharpless for her post-doctoral studies. She has over 30 issued patents and has been involved in multiple INDs in different therapeutic areas. She has deep connections in the medicinal chemistry community with long-time service to the ACS MEDI Executive Committee and was the elected Chair of the 2012 Medicinal Chemistry Gordon Research Conference. She is currently a SAB member at Caraway Therapeutics and Q BioMed. In her spare time, she plays classical violin professionally in and around the Boston area and has performed with such artists as Yo-Yo Ma, Hillary Hahn, Peter Gabriel, Sarah McLachlan and Smokey Robinson.

Experience

  1. CEO & Founder

    Lucy Therapeutics

    Jul 2017 — Present · Waltham, MA, US

Education

  • Northwestern University

    BA, Music and Chemistry

  • University of Wisconsin-Madison

    PhD, Chemistry

  • Scripps Research

    Post-Doc, Chemistry

Skills

  • Chemistry
  • Drug Discovery
  • Organic Synthesis
  • Organic Chemistry
  • Analytical Chemistry
  • Hplc
  • Drug Design
  • Pharmaceutical Industry
  • Clinical Development
  • Lifesciences
  • Chromatography
  • Lead Change
  • Ind
  • Technology Transfer
  • Pharmacology
  • Lc-Ms
  • Life Sciences
  • Drug Development
  • CRO
  • R
  • Medicinal Chemistry

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Amy Ripka — CEO & Founder at Lucy Therapeutics in Cambridge, MA, US | Unifers